Back
Anheuser-Busch InBev SA/NV Vs. Viking Therapeutics Industry Stock Comparison
Sell
32
BUD
Anheuser-Busch InBev SA/NV
Last Price:
58.82
Seasonality Move:
3.53%
Sell
45
VKTX
Viking Therapeutics
Last Price:
64.63
Seasonality Move:
38.04%
Sell
32
Anheuser-Busch InBev SA/NV (BUD)
is a Sell
Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?
- The current Anheuser-Busch InBev SA/NV [BUD] share price is $58.55. The Score for BUD is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- BUD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BUD Stock Price Chart
What is Anheuser-Busch InBev SA/NV's stock price today?
-
The Anheuser-Busch InBev SA/NV share price today is $58.55
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BUD is experiencing selling pressure, which indicates risk of future bearish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $63.14
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
BUD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.08 | Sell |
Relative Strength Index (14 RSI): | 22.46 | Sell |
Chaikin Money Flow: | -1069845 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.17 - 66.45) | Sell |
Bollinger Bands (100): | (59.76 - 64.34) | Sell |
VKTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.92 | Buy |
Relative Strength Index (14 RSI): | 44.37 | Sell |
Chaikin Money Flow: | -27799915 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (62.04 - 71.46) | Sell |
Bollinger Bands (100): | (52.9 - 66.58) | Buy |
BUD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 62.12 | Sell |
20-day SMA: | 63.8 | Sell |
50-day SMA: | 63.81 | Sell |
200-day SMA: | 61.96 | Sell |
8-day EMA: | 61.42 | Sell |
20-day EMA: | 63.08 | Sell |
50-day EMA: | 63.35 | Sell |
200-day EMA: | 61.95 | Sell |
VKTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 72.43 | Sell |
20-day SMA: | 67.48 | Sell |
50-day SMA: | 64.43 | Sell |
200-day SMA: | 59.82 | Buy |
8-day EMA: | 69.69 | Sell |
20-day EMA: | 68.14 | Sell |
50-day EMA: | 65.07 | Sell |
200-day EMA: | 55.33 | Buy |
Anheuser-Busch InBev SA/NV Earnings Growth & BUD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.43 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.
Anheuser-Busch InBev SA/NV Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Viking Therapeutics Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |